
    
      Healthy infants and toddlers will receive MenACYW conjugate vaccine or a licensed
      meningococcal vaccine, and routine pediatric vaccines.

      All participants will be assessed for immunogenicity before and after vaccination.

      Safety will be assessed throughout the study period, and includes solicited injection site
      and systemic reactions as well as unsolicited adverse events after each vaccine injection,
      and serious adverse events occurring throughout the study.
    
  